The investigators suggest that IL-6 might be the culprit and could, therefore, be a candidate for future studies of myositis therapy. Therapeutic options for patients with idiopathic inflammatory ...

I spent time with John Sarno, MD, at New York University School of Medicine, studying the relationship between pain and the brain, a condition he named tension myositis syndrome ... in learning more ...

The phase 1 clinical trial will evaluate the safety and efficacy of CLBR001 + SWI019 in patients with myositis ... Calibr-Skaggs' novel sCAR-T therapy is designed to reduce side effects and ...